137 related articles for article (PubMed ID: 26471225)
1. The InflammTORy Powers of Senescence.
Serrano M
Trends Cell Biol; 2015 Nov; 25(11):634-636. PubMed ID: 26471225
[TBL] [Abstract][Full Text] [Related]
2. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.
Laberge RM; Sun Y; Orjalo AV; Patil CK; Freund A; Zhou L; Curran SC; Davalos AR; Wilson-Edell KA; Liu S; Limbad C; Demaria M; Li P; Hubbard GB; Ikeno Y; Javors M; Desprez PY; Benz CC; Kapahi P; Nelson PS; Campisi J
Nat Cell Biol; 2015 Aug; 17(8):1049-61. PubMed ID: 26147250
[TBL] [Abstract][Full Text] [Related]
3. Cell signalling: Limiting the side effects of senescence.
Baumann K
Nat Rev Mol Cell Biol; 2015 Aug; 16(8):451. PubMed ID: 26177003
[No Abstract] [Full Text] [Related]
4. Translating the effects of mTOR on secretory senescence.
Tomimatsu K; Narita M
Nat Cell Biol; 2015 Oct; 17(10):1230-2. PubMed ID: 26419801
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T-cell senescence: no role for mTOR.
Henson SM
Biochem Soc Trans; 2015 Aug; 43(4):734-9. PubMed ID: 26551721
[TBL] [Abstract][Full Text] [Related]
7. Cell senescence, rapamycin and hyperfunction theory of aging.
Blagosklonny MV
Cell Cycle; 2022 Jul; 21(14):1456-1467. PubMed ID: 35358003
[TBL] [Abstract][Full Text] [Related]
8. From growing to secreting: new roles for mTOR in aging cells.
Pani G
Cell Cycle; 2011 Aug; 10(15):2450-3. PubMed ID: 21720215
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin and the inhibition of the secretory phenotype.
Wang R; Sunchu B; Perez VI
Exp Gerontol; 2017 Aug; 94():89-92. PubMed ID: 28167236
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia, MTOR and autophagy: converging on senescence or quiescence.
Blagosklonny MV
Autophagy; 2013 Feb; 9(2):260-2. PubMed ID: 23192222
[TBL] [Abstract][Full Text] [Related]
11. A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses.
Bent EH; Gilbert LA; Hemann MT
Genes Dev; 2016 Aug; 30(16):1811-21. PubMed ID: 27566778
[TBL] [Abstract][Full Text] [Related]
12. Gerosuppression by pan-mTOR inhibitors.
Leontieva OV; Blagosklonny MV
Aging (Albany NY); 2016 Dec; 8(12):3535-3551. PubMed ID: 28077803
[TBL] [Abstract][Full Text] [Related]
13. Alleviation of senescence and epithelial-mesenchymal transition in aging kidney by short-term caloric restriction and caloric restriction mimetics via modulation of AMPK/mTOR signaling.
Dong D; Cai GY; Ning YC; Wang JC; Lv Y; Hong Q; Cui SY; Fu B; Guo YN; Chen XM
Oncotarget; 2017 Mar; 8(10):16109-16121. PubMed ID: 28147330
[TBL] [Abstract][Full Text] [Related]
14. Aberrant mTOR activation in senescence and aging: A mitochondrial stress response?
Nacarelli T; Azar A; Sell C
Exp Gerontol; 2015 Aug; 68():66-70. PubMed ID: 25449851
[TBL] [Abstract][Full Text] [Related]
15. The PI3K/Akt/mTOR pathway regulates the replicative senescence of human VSMCs.
Tan P; Wang YJ; Li S; Wang Y; He JY; Chen YY; Deng HQ; Huang W; Zhan JK; Liu YS
Mol Cell Biochem; 2016 Nov; 422(1-2):1-10. PubMed ID: 27619662
[TBL] [Abstract][Full Text] [Related]
16. mTOR Inhibition Rejuvenates the Aging Gingival Fibroblasts through Alleviating Oxidative Stress.
Xia Y; Sun M; Xie Y; Shu R
Oxid Med Cell Longev; 2017; 2017():6292630. PubMed ID: 28804534
[TBL] [Abstract][Full Text] [Related]
17. mTOR signaling in disease.
Dazert E; Hall MN
Curr Opin Cell Biol; 2011 Dec; 23(6):744-55. PubMed ID: 21963299
[TBL] [Abstract][Full Text] [Related]
18. mTOR inactivation by ROS-JNK-p53 pathway plays an essential role in psedolaric acid B induced autophagy-dependent senescence in murine fibrosarcoma L929 cells.
Qi M; Zhou H; Fan S; Li Z; Yao G; Tashiro S; Onodera S; Xia M; Ikejima T
Eur J Pharmacol; 2013 Sep; 715(1-3):76-88. PubMed ID: 23810968
[TBL] [Abstract][Full Text] [Related]
19. The cell fate: senescence or quiescence.
Terzi MY; Izmirli M; Gogebakan B
Mol Biol Rep; 2016 Nov; 43(11):1213-1220. PubMed ID: 27558094
[TBL] [Abstract][Full Text] [Related]
20. In search of nutritional anti-aging targets: TOR inhibitors, SASP modulators, and BCL-2 family suppressors.
Sharma R; Padwad Y
Nutrition; 2019 Sep; 65():33-38. PubMed ID: 31029919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
